Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
qufengzhitong capsule
- Development stage
- Unknown
- Lead developer
- Guang'anmen Hospital
- Administration
- Oral
01
Overview
Qufengzhitong capsule is a Traditional Chinese Medicine (TCM) formulation developed by Guang'anmen Hospital of the China Academy of Chinese Medical Sciences for the treatment of rheumatoid arthritis (RA). As a hospital-made preparation (hospital-internal medicine), it is designed based on TCM principles to "expel wind, remove dampness, and relieve pain," addressing the "Wind-Cold-Dampness" pattern typically associated with arthritic conditions. The formulation is often used as an adjunctive therapy alongside conventional disease-modifying antirheumatic drugs (DMARDs) such as methotrexate. Clinical studies, including a Phase 4 multicenter trial in China, have evaluated its efficacy in improving ACR response rates and reducing systemic inflammatory markers like C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) in adult patients with active RA.
- Brand names
- Qufengzhitong capsule
- Other names
- 祛风止痛胶囊Qufeng Zhitong
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)IL1B (Interleukin-1 beta)
Beyond the preview
Go deeper on qufengzhitong capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on qufengzhitong capsule.